We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cortex Pharmaceuticals, | AMEX:COR | AMEX | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
Hot Features
Premium
RNS Number:2890T
Chorion PLC
15 December 2003
Chorion plc ("the Company")
Substantial Shareholder
The Company was informed by Merril Lynch Investment Managers on 15 December 2003
that it has an interest in 716,494 ordinary shares of 30p each in the Company
("Ordinary Shares"), representing 4.15% of the issued Ordinary Share capital.
The above shares are registered in the name of BNY Trust Company Ltd.
15 December 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLNKPKPOBDDFBD
1 Year Cortex Pharm Chart |
1 Month Cortex Pharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
